NRAD1 and breast carcinoma: In the case of LINC00284, also known as non-coding RNA in the aldehyde dehydrogenase 1 A pathway (NRAD1), it is upregulated in ovarian [41,42] and breast cancer cells [43] and also involved in angiogenesis in ovarian cancer cells [41].